000 | 01121 a2200313 4500 | ||
---|---|---|---|
005 | 20250515131413.0 | ||
264 | 0 | _c20090212 | |
008 | 200902s 0 0 eng d | ||
022 | _a1432-0738 | ||
024 | 7 |
_a10.1007/s00204-008-0344-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAdam, Oliver | |
245 | 0 | 0 |
_aAntioxidative effects of statins. _h[electronic resource] |
260 |
_bArchives of toxicology _cDec 2008 |
||
300 |
_a885-92 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCholesterol, LDL _xdrug effects |
650 | 0 | 4 |
_aEndothelium _xdrug effects |
650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xmetabolism |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 |
_aSecondary Prevention _xmethods |
700 | 1 | _aLaufs, Ulrich | |
773 | 0 |
_tArchives of toxicology _gvol. 82 _gno. 12 _gp. 885-92 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00204-008-0344-4 _zAvailable from publisher's website |
999 |
_c18147108 _d18147108 |